The pathogenesis of anxiety disorders is multifactorial, involving complex interactions between biological factors, environmental influences and psychological mechanisms. Recent advances have highlighted the role of epigenetics in bridging the gap between multiple contributing risk factors toward an increased understanding of the pathomechanisms underlying anxiety. In this review, we present an overview of the current state of knowledge regarding putative risk mechanisms in the pathogenesis of anxiety disorders, placing a particular focus on the role of protective factors serving to buffer a risk factor constellation and the role of epigenetic processes functioning as a potent turnstile changing passage direction toward disorder risk or resilience. We discuss promising future directions in epigenetic research regarding the prediction, prevention and personalized treatment of anxiety disorders.
Anxiety disorders constitute the most frequently occurring mental disorders worldwide. Prevalence rates of anxiety disorders as a group are estimated at 22.2% in the USA (Kessler et al. 2012) and 14% in the EU (Wittchen et al. 2011) per annum. Within the class of anxiety disorders -comprising specific phobias (SP), social anxiety disorder (SAD), agoraphobia (AG), panic disorder (PD), generalized anxiety disorder (GAD), separation anxiety disorder (SepAD) and selective mutism (SM) (American Psychiatric Association 2013) -SP are the most common (USA: 12.1%; EU: 6.4%; 12-month prevalence rate estimate), followed by SAD (USA: 7.4%; EU: 2.3%). The order of prevalence estimates regarding the remaining anxiety disorders differs somewhat between populations, with PD ranking third in the USA (2.4%) and fourth in the EU (1.8%), with GAD fourth and fifth (USA: 2.0%, EU: 1.7%), and AG fifth and third, respectively (USA: 1.7%; EU: 2.0%). Prevalence rates for SepAD and SM, newly added to the class of anxiety disorders in the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5; American Psychiatric Association 2013) after having previously been classified under 'Disorders Usually First Diagnosed in Infancy, Childhood, or Adolescence' in DSM-IV, are estimated at 1.0% (12-month prevalence; Silove et al. 2015) and between 0.03% and 0.2% (point prevalence; Sharp et al. 2007) , respectively.
Anxiety disorders are characterized by a considerably earlier age-of-onset (AOO) than other classes of mental disorders and typically first manifest during childhood and adolescence, with a median AOO of 11 years for the groups of anxiety disorders as a whole, although the AOO for single anxiety disorders varies considerably, with SP and SepAD presenting with the earliest AOO at age 7, followed by SAD at age 13, AG at age 20, PD at age 24 and GAD at age 31 (Kessler et al. 2005) . Childhood anxiety disorders often persist into adulthood or progress toward other anxiety disorders or other mental disorders across the life span (Beesdo-Baum & Knappe 2012) .
Anxiety disorders often co-occur with other mental disorders, e.g. depression or substance use and dependence (Kaufman & Charney 2000) . Women are affected approximately two times more frequently than men (Baxter et al. 2013) , although there do not appear to be any differences with regard to AOO, chronicity or the constellation of genetic and environmental risk factors between the sexes (Hettema et al. 2005; McLean et al. 2011) .
Anxiety disorders are one of the leading causes of disability worldwide. They present with high chronicity, ranking sixth among all -including somatic -disorders in terms of 'years lived with disability' (YLDs) and 'disability adjusted life years' (DALYs) at a rate of 389.7 DALYs per 100 000 people (Baxter et al. 2014) . Anxiety disorders account for a substantial amount of costs generated by mental disorders with an estimated 74.38 billion Euros in 2010, ranking fourth within the group of psychiatric and neurologic disorders after mood disorders, dementia and psychotic disorders, and accounting for approximately 9.3% of the total costs generated by these disorders combined (Olesen et al. 2012) .
The pathogenesis of anxiety disorders is complex, involving intricate interactions between biological factors, environmental influences and psychological mechanisms. In recent years, a growing body of research has spotlighted the role of epigenetic mechanisms in bridging the gap between multiple contributing putative risk factors, especially in light of the observation that the identified genetics risk variants thus far only serve to explain a fraction of the expected heritability of anxiety disorders, coined the 'hidden heritability' problem (Manolio et al. 2009 ). Here, we present an overview of the current state of knowledge regarding putative risk mechanisms in the pathogenesis of anxiety disorders while placing a particular focus on factors serving to buffer a risk factor constellation and the role of non-canonical modes of genetic influence, i.e. epigenetic processes at the interface of risk and resilience.
Genetics of anxiety
Family and twin studies indicate a substantial contribution of genetic factors in the pathogenesis of anxiety disorders. Anxiety disorders aggregate in families, with family studies reporting four-to sixfold increased odds of also suffering from an anxiety disorder in first-degree relatives of patients with PD, SP and GAD (Hettema et al. 2001) . Heritability estimates derived from twin studies range from 32% for GAD over 48% for PD and 51% for SAD, up to 67% for AG, with the remaining variance being attributed to environmental influences (Hettema et al. 2001; Kendler et al. 1999) . Unlike monogenic diseases, which are caused by mutations of a single gene, anxiety disorders do not follow a Mendelian mode of inheritance; rather, segregation analyses point to a complex-genetic inheritance pattern of anxiety traits, comprising an interaction of multiple susceptibility genes of small individual effect in addition to environmental influences (Vieland et al. 1996) . In accordance with a polygenic etiology model of anxiety disorders, linkage studies have identified several potential chromosomal risk loci that co-segregate with anxiety disorders in families (for review, see Maron et al. 2010) . Association studies have focused on the identification of risk variants, mostly single nucleotide polymorphisms (SNPs) in a priori defined candidate genes, e.g. genes related to monoaminergic function, neuropeptides, or hypothalamic-pituitary-adrenal (HPA) axis-related systems, and thus provided evidence for associations between variants in the monoamine oxidase A (MAOA) gene, the catechol-O-methyltransferase (COMT ) gene, the serotonin receptor 1A (5-HT1A) gene, the adenosine A2A receptor (ADORA2A) gene, the neuropeptide S receptor (NPSR1) gene or the corticotropin releasing hormone receptor 1 (CRHR1) gene (for a comprehensive overview of the pathogenetics of anxiety disorders, see Bandelow et al. 2016; Smoller 2016) . Recently, genome-wide association studies (GWAS) have yielded evidence for novel candidate genes contributing to the pathogenesis of anxiety disorders, for instance variants in the genes encoding the transmembrane protein 132D (TMEM132D; Erhardt et al. 2011) or the glycine receptor subunit beta (GLRB; Deckert et al. 2017) .
However, despite strong evidence for a considerable genetic influence on the pathogenesis of anxiety disorders, only a fraction of the risk genes contributing to the development of anxiety disorders has been identified, and findings have not been unequivocally replicated. The search for candidate genes is further complicated by complex comorbidity, etiological heterogeneity and unclear distinction between clinical and non-clinical anxiety (cf. McGrath et al. 2012) , calling for re-evaluation in well-defined, sufficiently powered samples.
Environmental and psychosocial factors at the intersection of risk and resilience
While heritability estimates indicate a considerable genetic contribution to the pathogenesis of anxiety disorders, they at the same time point to the involvement of environmental influences that account for the remaining variability not already explained by genetic factors (Hettema et al. 2005) . A large body of literature has thus focused on the identification of environmental and psychosocial influences driving risk or resilience toward anxiety.
On the side of risk factors, animal models have widely and convincingly demonstrated the detrimental effect of stressful experiences on developmental outcomes. Prenatal and neonatal stressors have been found to critically impair function of the HPA axis, the organism's major stress response system. Dysregulation of the HPA axis has been linked to impairments in brain maturation and function, and, consequently, a wide range of behavioral disruptions such as anxiety-or depressive-like behavior and impaired stress coping later in life (see Drury et al. 2016; Maccari et al. 2014; Weinstock 2017) . In humans, environmental adversity, e.g. traumatic and stressful life events, has repeatedly been linked to increased vulnerability to the development of anxiety disorders. Prenatal stress, e.g. high levels of anxiety or depression during pregnancy, has been reported to lead to long-term consequences in affected children, including cognitive impairment, physical health problems and the development of depressive and anxiety disorders . Given the early AOO of anxiety disorders as detailed above, a particular focus in the search for environmental risk factors has been placed on stressful and traumatic events occurring during childhood or early adolescence. Childhood constitutes a critical period of brain development that is characterized by high sensitivity to the effects of external influences on the programming of circuits underlying adult cognitive, emotional and behavioral functioning, and may therefore represent a 'window of vulnerability' during which adverse events can have a particularly harmful and long-lasting effect on neurodevelopmental processes (Andersen & Teicher 2008) . Indeed, traumatic experiences during childhood, e.g. physical/emotional abuse, physical/emotional neglect, loss/separation experiences or sexual trauma (e.g. Bandelow et al. 2002; Bandelow et al. 2004; Bishop et al. 2014; Cougle et al. 2010; Goodwin et al. 2005; Stein et al. 1996) , are associated with an approximately two-to fourfold increased risk for the development of PD, SAD or GAD later in life (Klauke et al. 2010; Fernandes & Osorio 2015) , although the frequency of particular trauma subtypes appears to differ somewhat between specific anxiety disorder diagnoses. For instance, a higher incidence of childhood sexual and physical abuse has been observed in PD patients compared with patients with SAD, whereas abuse frequency among GAD patients does not seem to differ significantly from either group (Safren et al. 2002) . Mirroring findings from the animal literature, early-life adversity, e.g. maltreatment, has been associated with hyperreactivity of the HPA axis in clinical populations (e.g. Heim et al. 2000; Elzinga et al. 2010 ; for review, see Faravelli et al. 2012 ) and brain structural and functional abnormalities, particularly pertaining to components of the 'fear circuit' such as amygdala, hippocampus and prefrontal cortex (e.g. Dannlowski et al. 2012; Frodl & O'Keane 2013; Jedd et al. 2015; Fonzo et al. 2016 ; see also Teicher et al. 2016) . Finally, negative life events in adulthood such as chronic or acute illness, bereavement/loss, separation events, threat experiences or financial problems often directly precede disorder onset. For instance, life events within a 12-month period have been observed to trigger subsequent PD onset (e.g. Faravelli 1985; Faravelli & Pallanti 1989; Faravelli et al. 2007; Scocco et al. 2007) , with as many as 80% of PD patients reporting at least one life event prior to experiencing their first panic attack (Uhde et al. 1985) . A higher cumulative number of adverse events has been reported to confer increased GAD risk (Roemer et al. 1996) , with a threefold increased risk for disorder onset after the experience of at least one major negative event (Blazer et al. 1987) , particularly for events related to loss or threat of future loss or trauma (Kendler et al. 2003) . A higher frequency of negative life events, especially related to death, health concerns or family/friends, has also been found to predict relapse in GAD patients (Francis et al. 2012) .
Taken together, there is converging evidence for a predisposing role of adverse experiences, particularly occurring during the sensitive period of childhood, in the pathogenesis of anxiety disorders. However, while negative environmental influences can have serious detrimental effects on mental health outcomes, many individuals do not go on to develop psychopathologies despite a history of adversity. An increasing body of research has thus focused on the identification of factors related to resilience that may counteract the deleterious impact of life stressors and possibly also serve to compensate for a biological risk profile. Accordingly, a wide range of resilience-promoting characteristics and mechanisms has been identified. For instance, availability of social support has consistently been linked to beneficial mental health outcomes, for example by buffering symptoms of anxiety (e.g. Hart & Hittner 1991; Howell & Miller-Graff 2014; Reinelt et al. 2014) . In a similar vein, positive cognitive emotion regulation strategies have been linked to resilient functioning and decreased risk of developing mental disorders such as anxiety or depression (Haeffel & Vargas 2011; Min et al. 2013; Poole et al. 2017) . Furthermore, factors shown to increase resilient functioning by buffering symptoms of anxiety and/or the effects of adverse experiences such as early exposure to violence or maltreatment include the employment of functional coping strategies, personality traits such as extroversion of conscientiousness, friendship and relationship quality, a secure attachment style or high levels of perceived self-efficacy (e.g. Endler et al. 2001; La Greca & Harrison 2005; Notzon et al. 2016; Schonfeld et al. 2016 ; see also Hoge et al. 2007; Feder et al. 2009; Festa & Ginsburg 2011; Rutten et al. 2013) .
Importantly, however, protective effects against the development of anxiety disorders are not exclusively conferred by the presence of explicitly positive influences or characteristics. Intriguingly, experiences of some adversity -depending on the quality, specificity, intensity, duration and timing of a stressor -may in fact also have beneficial consequences and thus promote resilient functioning. Such so-called 'stress inoculation' has elegantly been demonstrated in a series of studies in non-human primates and in rodent models, observing that short intervals of maternal separation experiences, while eliciting acute distress responses for the duration of the separations, result in decreased anxiety-related behavior and lower glucocorticoid levels over time, suggesting that early moderate stress may actually serve to facilitate resilience by promoting adaptive functioning when confronted with later stressors (e.g. Parker et al. 2004; Lyons et al. 2009; Brockhurst et al. 2015) . Likewise, similar research in humans has linked moderate levels of adversity to better mental health outcomes compared with high adversity and, importantly, no history of adversity (Seery et al. 2010; Seery et al. 2013) . Also, contrary to findings in clinical populations, participants with experiences of adverse events but no history of mental disorder have been found to actually display blunted cortisol responses to standardized stress protocols (Carpenter et al. 2007; Elzinga et al. 2008; Carpenter et al. 2011; Sumner et al. 2014) , indicating possible adaptive mechanisms counteracting the otherwise potentially negative consequences of stressful experiences and thus reflecting increased stress coping. Finally, expanding upon these findings, the sequence of adverse events appears to represent another hallmark criterion differentiating between risk and resilience, postulating that an increased vulnerability to mental disorders results from a 'mismatch' between early and adult environments and, consequently, an impaired ability to cope with challenge (Nederhof & Schmidt 2012) .
Gene-environment interactions
The above mentioned genetic and environmental factors do not act in isolation in the conferral of disorder risk but rather interactively with each other and thus, depending on their individual combination, can result in either negative or adaptive mental health outcomes. The interplay between genetic and environmental influences has been addressed in so-called gene-environment (G × E) approaches in the context of anxiety and anxiety disorders. For instance, an interaction between the short alleles of the 5-HTTLPR variant of the serotonin transporter gene and separation life events has been shown to increase PD risk (Choe et al. 2013) , while an interaction of neuropeptide Y (NPY ) gene variation with hurricane exposure has been reported in GAD (Amstadter et al. 2010) . Conversely, high social support has been shown to buffer SAD risk conferred by 5-HTTLPR variation (Reinelt et al. 2014) . Furthermore, G × E effects have also been reported in relation to dimensional anxiety traits in non-clinical populations. For example, the 5-HTTLPR long allele and the NPSR1 T risk allele have been found to interact with childhood maltreatment to increase anxiety sensitivity, constituting an intermediate phenotype predisposing to clinical anxiety, particularly PD (Klauke et al. 2011; Klauke et al. 2014) . While G × E models constitute a crucial step in the disentanglement of putative risk factors of anxiety, some of these results either did not withstand replication in independent samples, still require replication, or report contradictory findings regarding the allelic direction of association, which may, however, partly be reconciled by taking into account concurrent moderating influences. Recently, an extended approach to two-way G × E interaction models by simultaneously considering both stressful environmental circumstances and beneficial person characteristics such as coping strategies (C) in a G × E × C model revealed that high levels of general self-efficacy buffered vulnerability to anxiety as conferred by the interaction of childhood adversity and 5-HTTLPR genotype . This finding highlights protective qualities related to adaptive coping to be able to fully compensate for the otherwise deleterious effects of a G × E risk constellation.
Taken together, findings from G × E studies emphasize the complex nature of anxiety disorders and related traits, involving contributions from multiple domains that, depending on their individual constellation, can either increase or mitigate vulnerability to disease.
Epigenetics -the 'missing link'?
The term 'epigenetics' was originally coined by Conrad Waddington and, derived from the Greek prefix 'epi', literally translates to 'over' or 'above' genetics (Waddington 1942) . Epigenetic mechanisms comprise biological processes able to alter gene expression without changing the DNA sequence itself, and include DNA methylation, histone modifications such as acetylation or methylation of histone tails, or non-coding RNAs such as microRNAs (for review, see Schuebel et al. 2016) . Epigenetic mechanisms crucially govern gene function and have been shown to be in part temporally highly dynamic and responsive to both negative and positive environmental factors. Thus, epigenetic processes most probably constitute a key mechanism in the complex-genetic etiology of anxiety disorders or the conferral of resilience, respectively, and a potential 'missing link' in the 'missing heritability' of anxiety disorders.
Epigenetic mechanisms in animal models of anxiety
Results from animal models of anxiety have highlighted the role of epigenetic mechanisms in moderating responses to stressful environmental influences. This line of research has identified a variety of epigenetic alterations in response to acute as well as chronic stressors (e.g. maternal separation, low maternal care, chronic unpredictable stress, chronic mild stress) during different time windows of development (prior to conception, prenatal, postnatal, juvenile, adult age) in anxiety-relevant brain regions (limbic system, cortical system, hippocampus) (for a comprehensive overview of the current status of stress-and anxiety-related epigenetic research in animal models, please see Jawahar et al. 2015; Malan-Muller & Hemmings 2017; Nieto et al. 2016) . Exemplarily, in a landmark study, maternal rearing behavior was shown to differentially affect epigenetic mechanisms, resulting in altered hippocampal glucocorticoid receptor (Nr3c1) gene expression and aberrant HPA axis reactivity in the offspring of rats (Weaver et al. 2004) , thus proposing changes in negative feedback loop regulation of the HPA axis affecting glucocorticoid resistance as governed by epigenetic processes to be mechanistic in the conferral of stress coping. Furthermore, epigenetic mechanisms have been shown to dynamically regulate the formation, maintenance and extinction of fear memories in rodents as a model of clinical phenotypes related to phobia (cf. Kwapis & Wood 2014) . The transfer of these findings into human research is expected to greatly further our understanding of the mechanistic translation of risk-and resilience-conferring environmental factors into an anxiety-related phenotype against a genetic risk factor constellation as reviewed above and to open up novel and possibly individualized avenues in the development and application of pharmacological and psychotherapeutic interventions in anxiety disorders.
Epigenetic mechanisms in clinical anxiety

DNA methylation
In human research, so far efforts in epigenetic research have predominantly focused on DNA methylation. DNA methylation most commonly occurs at the 5 ′ position of the cytosine pyrimidine ring at cytosine-guanine dinucleotides (CpG) and is conferred by DNA methyltransferases (DNMTs). Regions with high density of CpG dinucleotides are termed 'CpG islands' and are mostly found in promoter regions of genes. Here, methylation results in a decreased gene transcription by for instance reducing affinity to transcription factors or by recruiting histone-modifying enzymes (for review, see Suzuki & Bird 2008; Moore et al. 2013) . Altered methylation patterns have been linked to clinical anxiety phenotypes per se, to dimensional phenotypes of anxiety both on a neuropsychological and a neurobiological level, to environmental influences as well as to treatment response and mechanisms (see below and Table 1) .
Association studies
First, DNA hypermethylation of the norepinephrine transporter (SLC6A2, NET ) was discerned in PD patients (Esler et al. 2006) , which, however, could not be replicated in a follow-up study (Bayles et al. 2013) . Furthermore, a significantly reduced DNA methylation in the region spanning the MAOA promoter, exon 1 and part of intron 1 was observed in female PD patients ), a finding that was successfully replicated . Panic disorder has also been associated with hypomethylation of the glutamate decarboxylase 1 (GAD1) gene relative to healthy controls (Domschke et al. 2013) . Similarly, significantly decreased methylation of the promoter region of the CRHR1 gene was observed in PD patients compared with healthy controls (Schartner et al. 2017) . On a functional level, employing a functional luciferase essay, non-methylation of the CRHR1 promoter region was shown to result in increased gene expression. Of relevance, the observed CRHR1 hypomethylation in PD patients was corroborated by decreased methylation of the same region in an independent sample of healthy participants with high levels of panic-related symptoms of anxiety compared with low-anxious probands, pointing to a precipitating role of CRHR1 hypomethylation and a resulting increased CRHR1 gene expression in the pathogenesis of PD (Schartner et al. 2017) . In SAD, relatively decreased methylation of the OXTR exon 3 region has been observed in cases compared with controls, supplemented by a negative association between OXTR methylation and dimensional measures of social anxiety . On a neurobiological intermediate phenotype level, OXTR methylation negatively correlated with the cortisol response to the Trier Social Stress Test (TSST) in healthy controls and amygdala activity levels upon exposure to social phobia-related words in SAD patients .
Conversely, increased OXTR exon 3 methylation was observed in a sample of older women with mixed diagnoses of anxiety and depression in a genotype-dependent fashion, emerging only in patients homozygous for the OXTR rs53567 A allele (Chagnon et al. 2015) . The same study also discerned increased BDNF methylation in the patient group, particularly in BDNF rs6265 T allele carriers. However, the small sample size of 19 cases and 24 controls and the heterogeneity of the clinical phenotypes assessed impede interpretation of these results.
Significantly increased DNA methylation levels in the promoter region of the glucocorticoid receptor (NR3C1) gene have been reported in a medication-free sample of patients with GAD. Additionally, this hypermethylation was inversely related to NR3C1 mRNA expression levels and glucocorticoid receptor sensitivity (Wang et al. 2017) . In a prospective approach, NR3C1 methylation was moreover found to predict lifetime internalizing disorder diagnosis and occurrence of internalizing symptoms, with higher methylation conferring increased risk for anxiety and/or depression (van der Knaap et al. 2015) .
Finally, recent efforts in advancing the understanding of the epigenetic underpinnings of anxiety disorders have addressed DNA methylation patterns on a genome-wide level. In an epigenome-wide association study (EWAS) using a methylation array assessing methylation status of more than 480 000 cytosine residues across the genome, PD was found to be associated with significant differential DNA methylation at 40 CpG sites, with mostly relative lower methylation levels in PD patients compared with controls (Shimada-Sugimoto et al. 2017) . Applying an epigenome-wide approach in a large cohort characterized for dimensional measures of anxiety, significantly increased DNA methylation at a single CpG site in the promoter of the ankyrin repeat and SOCS box protein 1 (ASB1) gene correlated with high levels of anxiety (Emeny et al. 2017) . In a sub-clinical population, high scores on the hospital anxiety and depression scale-anxiety (HADS-A) were discerned to be associated with elevated global DNA methylation levels and increased expression of the DNA methyltransferases DNMT1 and DNMT3A (Murphy et al. 2015) .
EpiG × environment interaction studies
Importantly, DNA methylation patterns seem to constitute dynamic signatures of environmental influences. For instance, decreased MAOA methylation was associated with a higher percentage of negative life events in female PD patients within 12 months prior to study inclusion, while reciprocally increases in MAOA methylation were linked to the occurrence of positive life events . Likewise, a significant negative correlation between GAD1 promoter methylation and negative life events was observed in PD (Domschke et al. 2013) .
In non-clinical populations, history of adversity has been linked to altered DNA methylation patterns, thus possibly constituting a risk factor for psychopathology. For instance, differential DNA methylation at 2868 CpG sites has been reported between 96 maltreated children and 96 control children (Yang et al. 2013) , and, with regard to specific gene loci, increased NR3C1 methylation has been observed in adolescents with a history of traumatic experiences during childhood and adolescence (van der Knaap et al. 2014 ) and during adulthood (Tyrka et al. 2012) . However, NR3C1 hypomethylation in combination with a history of childhood maltreatment has also been reported (Tyrka et al. 2016) . Aberrant OXTR methylation patterns have also been linked to experiences of childhood maltreatment and, interactively, to symptoms of anxiety and depression. Specifically, OXTR exon 1 hypomethylation was associated with a higher rate of symptoms of depression and anxiety in the presence of childhood abuse, whereas increases in OXTR exon 3 methylation were linked to symptoms of depression and anxiety and history of abuse (Smearman et al. 2016) .
Therapy-epigenetic studies
For clinical practice, the dynamic nature of DNA methylation patterns, particularly in terms of responsiveness to negative environmental influences as well as positive circumstances (cf. , poses a highly relevant area of research. Indeed, epigenetic research has inspired therapy-epigenetic approaches centered on the identification of epigenetic predictors and correlates of treatment response in anxiety disorders. DNA methylation patterns, for example hypomethylation of the serotonin transporter (SLC6A4, 5-HTT ) gene and the MAOA gene Domschke et al. 2015 ; for review, see Lisoway et al. 2017) , have been shown to predict responses to pharmacotherapeutic interventions in depression. In anxiety disorders, however, apart from a very small study in N = 4 patients with PD not having discerned changes in SLC6A2 (NET ) methylation along with selective serotonin reuptake inhibitor (SSRI) treatment (Bayles et al. 2013) , no studies have addressed epigenetic markers of pharmacotherapy outcomes so far. Conversely, a few studies have suggested epigenetic correlates of psychotherapy response in anxiety. For instance, in children diagnosed with a variety of anxiety disorders, increases in DNA methylation as conferred by a single CpG site in the promoter region of the SLC6A4 gene over the course of cognitive behavioral therapy (CBT) were related to successful treatment response, while treatment non-responders displayed relative decreases in DNA methylation at the same site (Roberts et al. 2014) . Better therapy response to CBT has also been associated with nominal increases in FK506 binding protein 5 (FKBP5) exon 1 percentage methylation changes from pre-to post-treatment at one CpG site in children and adolescents with DSM-IV anxiety disorder diagnoses, but only in FKBP5 risk allele carriers (Roberts et al. 2015) . In female PD patients, average MAOA methylation as well as methylation at eight single CpG sites in a region spanning exon 1/intron 1 was shown to significantly increase in treatment responders over the course of exposure-based CBT, whereas methylation levels of non-responders remained unchanged or even decreased. Importantly, after therapy DNA methylation levels in DNA responders no longer differed from those in healthy controls, suggesting the reversibility, i.e. normalization of an epigenetic risk profile by successful psychotherapy .
Histone modifications
The DNA is packaged around histone cores composed of eight histone molecules (H3, H4, H2A, H2B). Histone tails (amino terminals) can be subject to various post-translational modifications including acetylation or methylation crucially determining transcriptional activity (Kouzarides 2007) . Histone acetylation for instance is conferred by histone acetyltransferases (HATs) which results in an 'open' conformational state allowing for increased transcription, while decreased acetylation induced by histone deacetylases (HDACs) decreases accessibility of the DNA and thus silences gene expression (Jenuwein & Allis 2001) . Despite some evidence from animal studies for an important role of histone acetylation in the mediation of fear learning and fear extinction (e.g. see Bredy et al. 2007; Whittle et al. 2016; Ranjan et al. 2017; Siddiqui et al. 2017) , to the best of our knowledge no study has been published so far on histone modifications in human anxiety phenotypes.
MicroRNAs
MicroRNAs are small, about 22 nucleotide long singlestranded RNA molecules, which control single genes or entire gene networks by downregulation of gene expression upon interference with the 3 ′ -untranslated region (UTR) of one or several target mRNAs (for review, see Bartel 2004). MicroRNAs have been another target of epigenetic investigation in anxiety disorders and anxiety-related dimensional phenotypes (for review, see Hommers et al. 2015b; Martinetz 2016; Malan-Muller & Hemmings 2017) . For instance, variation in microRNAs miR-22, miR-138-2, miR-148a and miR-488 were found to be associated with PD or panic-related phenotypes (Muinos-Gimeno et al. 2011) . Furthermore, hsa-miR-4717-5p has been reported to downregulate expression of the Regulator Of G-Protein Signaling 2 (RGS2) gene, and two SNPs upstream to the host gene (rs150925, rs161427) have been associated with PD and increased dimensional panic-and agoraphobia related anxiety scores (Hommers et al. 2015a) . In a Korean sample, possible associations of miR-22 and miR-491 gene variants with PD were reported (Kim et al. 2015) . A miR-330-3p target site SNP (rs41305272) in mitogen-activated protein kinase 5 (MAP2K5) mRNA has been linked to AG (Jensen et al. 2014) . In GAD patients, circulating miR-4505 and miR-663 levels highly correlated with symptoms of anxiety (Hamilton Anxiety Scale, HAMA) . On a dimensional level, the T allele of the rs7194256 SNP in the 3 ′ UTR of the SLC6A2 (NET ) gene creating a binding site for the microRNA miR-19a-3p was linked to anxiety in a cardiovascular patient sample (Marques et al. 2016) . In response to a social stress task possibly relevant to SP-related anxiety, increased miR-29c expression was observed to correspond with both the experience of sustained stress and alterations in ventromedial prefrontal cortex functional connectivity (Vaisvaser et al. 2016) . Finally, moving toward a therapy-epigenetic framework, the expression of microRNAs has been shown to be temporally dynamic. For instance, although no direct association with anxiety levels/symptoms could be discerned, elevations in miR-144* levels have been observed in response to exam stress in a small sample of healthy students (Katsuura et al. 2012) , and in a mixed sample of patients with symptoms of depression/anxiety, miR-144-5p levels were shown to increase following psychotherapy (Wang et al. 2015) .
Discussion
Anxiety disorders and anxiety-related traits can result from the elaborate interplay of a multitude of genetic and environmental factors and mechanisms exerting their combined effects on a number of biological systems involved in the shaping of the phenotype. Despite several key advances in pre-clinical and clinical research, the dissection of putative risk factors of anxiety is still in its infancy. Studies on environmental factors of risk and resilience as well as extended gene-environment interaction analyses intertwined with research on epigenetic mechanisms exerting a non-canonical mode of genetic influence as reviewed above carry great potential for a better understanding of how multiple putative risk factors interact to increase susceptibility toward disease, and under which circumstances a risk factor constellation actually progresses from risk to manifestation of a disease, and under which circumstances it does not (see Fig. 1 ).
Windows of vulnerability
As detailed above, the impact of environmental influences on phenotypic variation may depend on the developmental stage during which they occur. Early developmental phases of high synaptic reorganization have been discussed to constitute particularly sensitive 'windows of vulnerability' to stress, which are associated with impaired neurodevelopmental outcomes mediating vulnerability to mental disorders (Andersen & Teicher 2008) . For instance, consistent with a G × E × T (timing) concept, stress in pre-pubertal or adolescent developmental phases has been shown to differentially influence structural integrity of specific brain regions as well as emotion regulation in a rat model depending on genetic background (Zalsman et al. 2015) . Evidence for exposuresensitive periods of the developing brain and the behavioral consequences of environmental insults during these critical phases largely stems from studies in rodents or non-human primates, necessitating caution when translating these findings from animal models to humans. However, research in humans, although mostly correlational given ethical concerns, has been shown to parallel findings from the animal literature, pointing to childhood as a critical period for the effects environmental insults on long-term neurodevelopmental and, ultimately, behavioral consequences (see Lupien et al. 2009; Teicher et al. 2016) . Of note, the manifestation of disease attributed to early adversity occurs at a delay -for example, an average delay of approximately 11 years between the experience of adversity and depression onset has been reported (Teicher et al. 2009 ). However, findings should be interpreted cautiously and should ideally be complemented by future longitudinal twin or adoption studies on G × E × T interactions spanning key developmental periods and including brain function measures (cf. Zalsman 2010) . Besides the role of stressful events occurring during childhood in the susceptibility to anxiety disorders, prenatal influences also crucially affect behavioral and biological outcomes in offspring. In humans, maternal well-being during pregnancy, e.g. anxiety or depression, has been suggested to influence epigenetic constellations in the child (for review, see Ryan et al. 2017) . These particular phases of high sensitivity to the early environment could explain the early AOO of anxiety disorders and -on a positive note -may actually represent 'windows of opportunity' (Andersen 2003) for protective environmental influences to facilitate resilient functioning, e.g. conferred by effective early preventive interventions in adversity-exposed children or mothers during pregnancy.
G × E interaction -adding a dimension
It is commonly understood that genetic factors interact with the environment in conveying vulnerability to anxiety in accordance with the 'vulnerability-stress model' (Zubin & Spring 1977) , which proposes that some individuals are rendered disproportionally more vulnerable to environmental adversity due to inherent risk factors (i.e. genetic predisposition). Recent advances in G × E research have argued for a reconceptualization of classical risk factor models in favor of the 'differential susceptibility hypothesis' ) -away from the classical understanding of 'risk genes' and toward a definition of 'plasticity genes'. Despite some open methodological issues such as the fact that for example in the case of 5-HTTLPR, based on the literature both the short and long allele could be proposed as 'plasticity' alleles, this model is useful in suggesting that genes moderate responses to the entirety of the environmental spectrum, i.e. are equally responsive to both positive and negative environmental influences, which, depending on their individual constellation, can result in both negative and beneficial outcomes. Because negative environments on one end, i.e. the occurrence of stressful life events, and positive influences on the other are not mutually exclusive, the simultaneous consideration of both detrimental and beneficial influences in synopsis with genetic variation constitutes a pivotal gateway at the intersection of risk and resilience, which, however, has only sparsely been addressed so far. Extending classical G × E two-way interaction models, in which the environmental component (E) is typically defined in terms of adverse events, by taking also into account positive factors as an additional dimension representing successful coping with adversity (C), into a three-dimensional G × E × C model, in which coping-related factors can serve to buffer an otherwise risk-increasing constellation (cf. Schiele et al. 2016) , may thus substantially add to the current state of understanding of the pathogenesis of anxiety disorders.
Epigenetics at the crossroads between G, E and C
Epigenetic mechanisms have convincingly been shown to reflect the biological impact of risk-as well as resilience-conferring environmental influences, possibly explaining a considerable portion of the 'missing heritability' of anxiety disorders. Yet, despite this great advance in our efforts to better understand the complex etiology of anxiety disorders at this point the 'missing link' debate could be reignited: this time regarding the question which biochemical mechanisms broker this crosstalk between environmental stressors and epigenetic responses. One lead has been provided by studies suggesting glucocorticoids as a marker of HPA axis activation in response to stress to associate with glucocorticoid receptors and -by functioning as a transcription factor in the nucleus -to initiate a host of epigenetic modifications (cf. Zannas & Chrousos 2017) . However, the exact nature of the mechanistic link between environmental influences and epigenetic mechanisms remains to be elucidated. Longitudinal studies are thus needed synoptically taking into account the individual genetic background, risk as well as protective environmental factors, endocrine measures reflecting HPA axis activity and finally epigenetic mechanisms functioning as a potent turnstile changing passage direction toward disease risk or resilience of anxiety disorders.
Future efforts might furthermore be directed at exploring the role of epigenetic mechanisms not only in categorical anxiety disorder phenotypes, but also in intermediate phenotypes of anxiety such as neural network function applying an 'imaging epigenetic' approach (cf. Domschke & Dannlowski 2010) or in constructs of negative affect as captured by the NIMH's Research Domain Criteria domain of negative valence systems (cf. Savage et al. 2017) possibly reflecting the expected intricate epiG × E × C interactions more closely.
On a more technical note, similar to GWAS, results from EWAS in sufficiently large samples can yield new impulses in the decoding of specific gene systems contributing to the pathogenesis of anxiety disorders. Importantly, given the polygenic etiology of anxiety disorders, cumulative as well as epistatic genetic effects should be taken into account, for instance utilizing poly(epi)genic risk scores (Dudbridge 2013) , ideally in epigenome-wide epiG × E × C interaction approaches, which may further be complemented by what has been suggested as 'poly-environmental scores' (Uher & Zwicker 2017) . Also, the cross-talk between different epigenetic mechanisms, i.e. the effect of the entirety of the epigenetic machinery in shaping one particular phenotype of interest poses a biochemically as well as bioinformatically challenging question to solve in future studies (cf. Molina-Serrano et al. 2013) .
Epigenetic interactions
To further complicate the picture, epigenetic mechanisms do not only seem to function as a translator between the environment and the genetic background, but might actually be determined by genetic variation itself. For instance, DNA methylation has been shown to frequently occur in an allele-specific manner (cf. Meaburn et al. 2010) . Correspondingly, a negative association between childhood maltreatment and DNA methylation in an intronic region of the FKBP5 gene has been observed in an allele-specific manner (Klengel et al. 2013) . Similar allele-specific effects have also been reported in the context of acute stress responding (Alexander et al. 2014; Duman & Canli 2015) . Allelespecific methylation may thus provide one explanation for non-replications and contradictory findings regarding the allelic direction in genetic association studies and G × E research, highlighting the necessity for the incorporation of epigenetic information in all genetic risk factor models of anxiety disorders including the mapping of methylation quantitative trait loci (mQTLs) and haplotype-dependent allele-specific DNA methylation (hap-ASM) (cf. Do et al. 2017) . Along these lines, it has to be taken into consideration that the epigenetic machinery itself, such as DNA methyltransferases (DNMT1, DNMT3A, DNMT3B), methylenetetrahydrofolate reductase (MTHFR), HDACs or even histones per se, is encoded genetically and can be modified epigenetically. So far, only very few studies have looked into the role of genetic and epigenetic variation in genes driving the epigenetic machinery in the context of anxiety-or stress-associated behavior (e.g. Murphy et al. 2013; Pishva et al. 2014; Maddox et al. 2017) . Thus, futures studies will have to put a major focus on elucidating the complex genetic-epigenetic interaction in shaping anxiety-related phenotypes.
Sex matters
The observation that anxiety disorders are approximately twice as common among women than men (Baxter et al. 2013) and are moreover associated with a greater burden of illness in women (McLean et al. 2011 ) has inspired first research into the potential role of the epigenetic machinery in driving sexual differentiation of the brain by shaping sexually dimorphic brain circuits and expression of steroid hormone receptors and in setting the course for later behavioral and phenotypic differences, possibly through complex interactions with hormonal systems (cf. Uddin et al. 2013) . For instance, a significant negative correlation of serum estradiol levels and OXTR DNA methylation was observed in patients with post-partum depression (Kimmel et al. 2016) , and 17 -estradiol (E2) has been shown to differentially alter miRNA levels in an age-and brain region-dependent manner (Rao et al. 2013) . Thus, future studies in anxiety disorders might want to take into account information on hormonal status in order to identify possible sexually dimorphic (epi)gene-hormone interactions.
The 'tissue issue'
As nicely put by Bakulski et al. (2016) , one caveat in interpreting all presently available evidence for epigenetic mechanisms in anxiety is the 'tissue issue', i.e. the fact that so far DNA methylation or miRNA-related variation has been assessed in peripheral tissue not readily allowing for conclusions regarding central nervous system processes. However, given the difficulty to obtain relevant brain tissue from patients or probands in vivo, the identification of epigenetic patterns in surrogate peripheral biomaterial as a proxy for brain epigenetic markers is hoped to contribute to the development of reliable biomarkers for anxiety disorders (cf. Gladkevich et al. 2004; Tost 2010) . Some evidence supports this notion: in rats, for instance, a direct correlation between COMT methylation in peripheral mononuclear blood cells (PBMCs) and the prefrontal cortex (PFC) was found (Ursini et al. 2011) . Comparing genome-wide methylation patterns of blood and brain samples (PFC) in monkeys indicated a ∼50% functional overlap in DNA methylation profiles in T lymphocytes and PFC (Provencal et al. 2012) . A landmark study discerned that some inter-individual variation in DNA methylation in humans was reflected across brain and whole blood (Davies et al. 2012) . Finally, applying a very elegant in vivo intra-individual approach, a positron emission tomography (PET) study using [(11)C]clorgyline discerned peripheral MAOA methylation measured in leukocytes to inversely correlate with brain MAOA levels suggesting DNA methylation in blood as a viable sensor for central processes (Shumay et al. 2012) .
Transgenerational epigenetics
Besides evidence for epigenetic patterns in the offspring being modified by prenatal stress within the maternal uterine environment (see above), animal studies suggest a potential transgenerational inheritance of epigenetic patterns via multiple mechanisms conferred by paternal sperm and maternal germline (for review, see Daxinger & Whitelaw 2012; Heard & Martienssen 2014; Klengel et al. 2016; Gapp & Bohacek 2017) potentially reflecting ancestral stress and impacting anxiety-related mental health in offspring by shaping endocrine programming, brain development and ways to cope with stress (for review, see Babenko et al. 2015) . Exemplarily, a recent study pointed to epigenetic inheritance of ancestral odor fear conditioning in mice possibly via transferal of sperm DNA methylation signatures to F1 and F2 generations (Dias & Ressler 2014; see comment by Szyf 2014) . Also, in a paternal stress mouse model nine specific microRNAs were observed to be differentially expressed in sperm impacting offspring HPA stress axis regulation (Rodgers et al. 2013) . No study so far, however, has investigated transgenerational transmission of environmentally coined epigenetic patterns in human anxiety disorders, and evidence from studies in anxiety-related phenotypes is mostly correlational. For instance, in post-traumatic stress disorder (PTSD) Yehuda et al. (2016) have reported Holocaust exposure-driven alterations in FKBP5 methylation to be observable in both exposed parents and their offspring. Therefore, the 'if' and 'how' of transgenerational transmission of 'epigenetic scars' in general and in anxiety-related phenotypes in particular remains to be elucidated (see Heard & Martienssen 2014 ).
Outlook and conclusion
The integration of multilevel putative risk factor constellations carries exceptional potential for novel preventive and therapeutic avenues in psychiatry. Composite markers, i.e. (epi)G × E × C interactions analyzed on an individual level preferably using machine learning algorithms might serve as valuable predictors of disease risk and thus as indicators for targeted prevention approaches toward providing the most effective preventive interventions especially in critical time windows of development. Furthermore, epigenetic research holds great promise regarding the development of personalized treatment options. This is of particular relevance given the fact that 20-40% of patients with anxiety disorders do not respond sufficiently to the initial mode of treatment (Bystritsky 2006) , which is associated with poor quality of life, high rates of suicidal attempts and considerable socioeconomic consequences as detailed above (Olesen et al. 2012) . Therefore, the identification of epigenetic predictors of treatment response may inform individually tailored treatment options, e.g. low MAOA methylation conferring increased MAOA activity might be counteracted by the MAOA inhibitor moclobemide as an adjunct to SSRI antidepressant treatment (cf. Domschke et al. 2015) . Given that several antidepressants used as first-line agents in the treatment of anxiety disorders have already been shown to modify DNA methylation or histone acetylation (for review see Boks et al. 2012) , epigenetic research may lead to the development of novel, innovative treatment options such as HDAC inhibitors (HDACi) directly targeting epigenetic processes in a safe and anxiety-related cell-specific manner (cf. Whittle & Singewald 2014) . Taken together, the field of epigenetics provides novel perspectives highly relevant to deciphering the synergistic mechanistic links as well as the complexity of their interactions underlying risk and resilience toward anxiety and holds great promise for the design of prospective preventive and individualized therapeutic options in the overall effort to more effectively lower the high individual and socioeconomic burden of anxiety disorders.
